Pharmaceutical Waste Incinerators

A pharmaceutical waste incinerator is a dual-chamber thermal destruction unit specified for medicinal products and the materials contaminated by them. What separates it from a general-purpose unit is less the combustion engineering than what the operation has to produce: a run that can be reconciled against a batch number, evidenced with a temperature record, and closed with a certificate of destruction that an MHRA inspector or a Home Office authorised witness will accept. The combustion condition is the one the Industrial Emissions Directive sets for any waste incineration plant — flue gas held above 850°C for two seconds in a secondary chamber with the primary between 850°C and 1,200°C — and it rises to 1,100°C where the charge carries more than 1% halogenated organic content. Pharmaceutical charges hit that threshold more often than most: PVC and PVdC blister films, chlorinated actives and fluorinated excipients all count towards it, which is why the 1,100°C capability is stated here rather than buried in a footnote. The LitBurn LBI range covers 125, 250, 375 and 500 kg/h. Unlike the batch ranges these are continuous-duty units, front-loaded through a dual door at floor level, so throughput is a function of operating hours rather than cycles and a returns hall feeds the unit from the cages the stock is already sitting in. Six pharmaceutical streams are specified separately below because each has a different reason for being destroyed and a different thing the paperwork has to say about it. Expired stock is reconciled against a batch number; a recall is destroyed under a GMP procedure; controlled drugs need denaturing and an authorised witness; cytotoxics carry their own hazardous classification. The unit is the same. The procedure, the exclusions and the record are not.

Because the transfer is the part that carries the risk. Once expired stock, a recalled batch or a denatured controlled drug leaves the site it is in someone else's chain of custody, and you are relying on a certificate rather than on having watched it happen. On-site incineration removes the transfer — the material is destroyed where it was quarantined, by staff already inside your quality system, and the certificate is issued against a temperature record you hold.

Yes. The primary chamber runs 850–1,200°C and the secondary holds gas above 850°C for two seconds as standard, rising to 1,100°C where the stream carries more than 1% halogenated organic content. Pharmaceutical charges reach that threshold routinely — PVC and PVdC blister films are the usual reason — so the higher condition should be declared in the permit application rather than treated as an exception.

Yes, and most sites specify it that way. Expired stock, recalled product, contaminated packaging, laboratory waste and denatured controlled drugs all destroy at the same condition, so a single permitted LitBurn covers them provided every stream is named with its waste codes in the application. Cytotoxic and cytostatic waste is the one to check carefully: it is hazardous under 18 01 08* and needs its own permitted scope.

Size on hours, not on charges — these are continuous-duty units. Divide your weekly or monthly arisings by the hours you are prepared to run and match that against the burn rate. The LBI-125 clears roughly a tonne in eight hours and suits a returns hall or a single manufacturing site; the LBI-375 and LBI-500 suit a regional destruction point or a plant clearing production rejects alongside its medicinal waste.

No, and it should not be. De-blistering expired stock creates a handling step, an exposure risk and a diversion opportunity that charging the intact pack avoids entirely. Blisters, bottles, ampoules and cartons go into the charge as they come out of quarantine. The only pre-treatment that is ever required is denaturing controlled drugs, and that is a legal step rather than a combustion one.

Three things the unit produces: the reconciled manifest of what went in, the time-stamped chamber temperature log for the run, and the ash weight at 3–5% of input mass. Those are the records an MHRA inspector, a returns auditor or an authorised controlled-drugs witness will ask to see. A certificate issued without them is an assertion, not evidence.

No. Residue is 3–5% mineral ash with no recoverable dose form and no active molecule left intact — that is what the 850°C two-second condition is for. It leaves the site as ordinary waste under a transfer note, unless the charge included hazardous material such as cytotoxics, in which case the residue classification follows the permit and should be agreed with the regulator at application stage.

Yes, and for controlled drugs it must be. The charge door is interlocked and the run is logged, so a nominated witness can be present for the charge and sign against the cycle record. For Schedule 2 drugs the witness has to be a person authorised under the Misuse of Drugs Regulations 2001, and the denaturing step happens before the material reaches the unit.